MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported preliminary and unaudited financial results for the three-month period ...

MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that it has completed the divestiture of its Central Labs operations to ...

MDS Inc, parent company of radioisotope producer MDS Nordion, is to write off the value of its assets in the abandoned MAPLE reactor project. MDS Inc, parent company of radioisotope producer MDS ...

OTTAWA, Sept 7 (Reuters) - After two years of heavy lifting, MDS Inc.'s corporate makeover is largely complete, but Chief Executive Stephen DeFalco still has ambitious plans to grow the business. As ...

MDS Pharma Services reported adjusted EDITDA of US$1 million in the negative for the second quarter, while the CRO’s net revenues rose by 11.3% to US$128 million. Third-quarter results will be issued ...

The offer is not conditional upon any minimum number of Common Shares being deposited; however, the offer is subject to certain other conditions. Full particulars of the terms and conditions of the ...

TORONTO , Sept. 17 /CNW/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that Steve West , President of MDS Nordion, ...

"We have had to resort to taking these steps to protect the interests ofpatients, the nuclear medicine community, our shareholders and our customers,"said Stephen P. DeFalco, President and CEO, MDS ...

The prolonged shutdown of a Canadian isotope producing reactor has contributed to a "strategic repositioning" decision by life sciences company MDS Inc that will see it sell off its non radioisotope ...

After a six-month hiatus, MDS Proteomics Inc. is gearing up to revive an aborted initial public offering estimated at $250-million (U.S.). "None of us feels the market is stable today because nobody ...